Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.

@article{Ferrone2006PerioperativeCL,
  title={Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.},
  author={Cristina R Ferrone and Dianne M. Finkelstein and Sarah P. Thayer and Alona Muzikansky and Carlos Fernandez-delCastillo and Andrew Louis Warshaw},
  journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology},
  year={2006},
  volume={24 18},
  pages={2897-902}
}
PURPOSE Different prognostic factors stratify patients with pancreatic adenocarcinoma. The purpose of this study was to determine whether preoperative CA19-9 levels can predict stage of disease or survival and whether a change in preoperative to postoperative CA19-9 or the postoperative CA19-9 predicts overall survival. PATIENTS AND METHODS Four hundred twenty-four consecutive patients with pancreatic adenocarcinoma underwent resection between January 1, 1985 and January 1, 2004. Of the… CONTINUE READING
Highly Influential
This paper has highly influenced 13 other papers. REVIEW HIGHLY INFLUENTIAL CITATIONS
168 Citations
17 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 168 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 17 references

Pancreatic adenocarcinoma, in the American Joint Committee on Cancer Staging Handbook (6 ed)

  • FL Greene, DL Page, ID Fleming
  • 2002

Similar Papers

Loading similar papers…